Roche rejoint Moderna pour inclure le test d’anticorps dans l’essai du vaccin Covid

Moderna’s vaccine, which in late-level trials with extra than 30,000 members confirmed efficacy of 94% in stopping COVID-19, is designed to cause an antibody reaction to proteins discovered at the coronavirus spike’s receptor binding area. Roche stated its test, carried out in a laboratory placing and requiring a blood draw, can set up a correlation among vaccine-precipitated safety and tiers of receptor-binding area antibodies.

Be the first to comment on "Roche rejoint Moderna pour inclure le test d’anticorps dans l’essai du vaccin Covid"

Leave a comment

Your email address will not be published.


*